• OPEN AN ACCOUNT
Indian Indices
Sensex
77,540.83 3.11
( 0.00%)
Global Indices
Nasdaq
53,294.39 514.18
(0.97%)
Dow Jones
7,693.51 31.35
(0.41%)
Hang Seng
65,893.13 -323.66
(-0.49%)
Nikkei 225
10,809.01 60.85
(0.57%)
Forex
USD-INR
95.67 0.05
(0.05%)
EUR-INR
111.76 0.57
(0.51%)
GBP-INR
130.35 0.55
(0.42%)
JPY-INR
0.60 0.00
(0.11%)

EQUITY - MARKET SCREENER

Larsen & Toubro Ltd
Industry :  Engineering - Turnkey Services
BSE Code
ISIN Demat
Book Value()
500510
INE018A01030
541.716552
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LT
41.86
562460.94
EPS(TTM)
Face Value()
Div & Yield %
97.67
2
0.93
 

Balaxi Pharmaceuticals consolidated net profit declines 92.94% in the March 2026 quarter
May 29,2026
Net profit of Balaxi Pharmaceuticals declined 92.94% to Rs 0.61 crore in the quarter ended March 2026 as against Rs 8.64 crore during the previous quarter ended March 2025. Sales declined 7.29% to Rs 70.71 crore in the quarter ended March 2026 as against Rs 76.27 crore during the previous quarter ended March 2025.

For the full year,net profit declined 94.34% to Rs 1.42 crore in the year ended March 2026 as against Rs 25.07 crore during the previous year ended March 2025. Sales declined 7.65% to Rs 270.17 crore in the year ended March 2026 as against Rs 292.56 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales70.7176.27 -7 270.17292.56 -8
OPM %0.1716.45 -3.1612.72 -
PBDT2.0510.12 -80 7.4530.56 -76
PBT1.409.66 -86 5.2928.67 -82
NP0.618.64 -93 1.4225.07 -94